Runben Biotechnology Co., Ltd. (SHA:603193)
26.62
+0.65 (2.50%)
May 6, 2026, 3:00 PM CST
-31.11% (1Y)
| Market Cap | 10.77B -24.2% |
| Revenue (ttm) | 1.57B +13.0% |
| Net Income | 322.94M +4.6% |
| EPS | 0.80 +5.5% |
| Shares Out | 404.59M |
| PE Ratio | 33.30 |
| Forward PE | 28.62 |
| Dividend | 0.46 (1.77%) |
| Ex-Dividend Date | n/a |
| Volume | 6,978,747 |
| Average Volume | 7,033,825 |
| Open | 26.00 |
| Previous Close | 25.97 |
| Day's Range | 25.88 - 26.78 |
| 52-Week Range | 20.28 - 44.00 |
| Beta | 0.41 |
| RSI | 60.83 |
| Earnings Date | Apr 23, 2026 |